MedPlus Health Services Limited has informed exchanges that its subsidiary, Optival Health Solutions Private Limited, has received two suspension orders pertaining to drug licenses for its retail outlets in Telangana.
According to the regulatory filing dated July 31, 2025, the Drug Control Administration, Warangal, issued the following suspension orders:
- Store at Station Ghanpur: License suspended for five days
- Store at Girinigadda Main Road, Jangaon: License suspended for three days
These actions were taken under Rule 65 of the Drugs and Cosmetics Act, 1940, and the Drugs and Cosmetics Rules, 1945. The orders were received on July 30, 2025.
Financial Impact
The suspension is expected to result in:
- An estimated revenue loss of ₹0.98 lakh from the Station Ghanpur store
- A ₹0.40 lakh loss from the Girinigadda store
The company clarified that while the impact is minimal and localized, it is fully cooperating with the authorities to comply with all regulatory directives.
The announcement has been made public in compliance with SEBI disclosure norms and is available on the MedPlus website and stock exchange portals.
